Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 76   

Articles published

DPH 975.00 -22.00 (-2.21%)
price chart
Brokerages Set Dechra Pharmaceuticals plc (LON:DPH) Price Target at $1071.14
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has received a consensus rating of “Hold” from the nine brokerages that are presently covering the company, Market Beat.
Are GlaxoSmithKline plc, Dechra Pharmaceuticals plc & CareTech Holdings plc On ...
For example, Dechra (LSE: DPH) has been able to increase its earnings at a double-digit rate in each of the last three years, with it rising at an annualised rate of 23% during the period.
Dechra Pharmaceuticals plc (DPH) Rating Reiterated by Panmure Gordon
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH)'s stock had its “buy” rating reissued by stock analysts at Panmure Gordon in a research report issued on Thursday, ARN reports.
Dechra Pharmaceuticals plc (DPH) Earns "Buy" Rating from Panmure ...  Intercooler Financial
Are Genus plc And Dechra Pharmaceuticals plc Better Buys Than GlaxoSmithKline plc?
While shares in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) have disappointed in the last year, it has not been the same story for a number of its pharmaceutical rivals. In fact, shares in Genus (LSE: GNS) and Dechra (LSE: DPH) have soared in the last 12 ...
Are AstraZeneca plc, Indivior PLC & Dechra Pharmaceuticals plc Set To Double ...
If you are looking for relatively stable cash flows and solid balance sheets in a volatile market, there is a good chance that you may be right to invest in the pharmaceuticals sector right now. That works in theory, at least - but is there also a ...
Why AstraZeneca plc, Dechra Pharmaceuticals plc And Tissue Regenix Group PLC ...
AstraZeneca (LSE: AZN), Dechra Pharmaceuticals (LSE: DPH) and Tissue Regenix (LSE: TRX) represent a great healthcare combination.
International Veterinary Pharmaceutical Business Dechra Pharmaceuticals PLC ...  PR Newswire (press release)
Dechra Pharmaceuticals grows profit again  Interactive Investor
Dechra Pharmaceuticals plc (DPH) Given Buy Rating at Jefferies Group
Dechra Pharmaceuticals plc logo Jefferies Group reaffirmed their buy rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a research note released on Thursday morning, Market Beat reports.
Dechra� Pharmaceuticals PLC (Dechra or the Group) : Trading Update  PR Newswire (press release)
Dechra Pharmaceuticals plc 6.5% Potential Upside Indicated by Jefferies ...  DirectorsTalk Interviews
Dechra� Pharmaceuticals PLC: Trading Update
In the first quarter, our European Pharmaceuticals Segment increased revenues by 11% at CER (0% at AER). The growth was driven by Companion Animal Products (CAP) which were ahead of our expectations.
Dechra drug sales to vets grow fast  Interactive Investor
Dechra Pharmaceuticals plc (LON:DPH) Receives Average Rating of "Hold" from ...
Dechra Pharmaceuticals plc logo Shares of Dechra Pharmaceuticals plc (LON:DPH) have been given a consensus rating of “Hold” by the nine ratings firms that are presently covering the company, Market Beat reports.
Why I'd Buy GlaxoSmithKline plc Before Dechra Pharmaceuticals plc Or Al Noor ...
For investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US), the last few years have been very challenging. That's because the company's bottom line has fallen by 17% during the last three years as sales have come under pressure from generic products ...